Roux-en-Y Gastric Bypass as an Emergency Procedure for Resolving SADI-S Leak
Publication date: Available online 28 November 2018Source: Cirugía Española (English Edition)Author(s): Juana Morante Castaño, Jorge H. Carlin Gatica, Pilar Veguillas Redondo, Roberto de la Plaza Llamas, Jose Manuel Ramia Angel
In this study, we aimed to investigate the effect of PAS on the feasibility and safety of laparoscopic Roux-en-Y gastric bypass surgery (LRYGB) in patients with obesity and type 2 diabetes mellitus (T2DM).
AbstractBackgroundObesity is closely linked to increased markers of metabolic syndrome and development of diabetes. Roux-en-Y bariatric surgery reduces hyperinsulinemia and improves insulin sensitivity and hence benefits morbidly obese patients.AimTo determine changes in markers of metabolic syndrome, pancreatic function, and hepatic insulin sensitivity in patients before and 1 year after undergoing Roux-en-Y gastric bypass surgery.MethodsWe enrolled 43 consecutive patients in a single center. Markers for metabolic syndrome included proinsulin, insulin, C-peptide, liver enzymes, and serum levels of selected microRNAs...
(Reuters Health) - People with obesity may initially shed more excess pounds with an older operation known as Roux-en-Y gastric bypass than with a newer sleeve gastrectomy procedure, but a research review suggests that longer-term, which one is better for weight loss remains unknown.
ConclusionAlthough Meckel’s diverticulitis is a rare entity, it can appear as an acute abdomen. An early diagnosis and treatment to prevent subsequent complications is essential to ensure an optimal recovery.
AbstractIntroductionSleeve gastrectomy (SG) has overtaken Roux-En-Y gastric bypass (RYGB) as the most common bariatric procedure worldwide. However, there is little long-term data comparing the two procedures.ObjectivesWe perform a systematic review and meta-analysis comparing 5-year outcomes of randomised controlled trials (RCTs) comparing RYGB and SG.MethodsMedline, Embase, The Cochrane Library, and NHS Evidence were searched for English language RCTs comparing RYGB with SG and assessed weight loss and/or comorbidity resolution at 5 years.ResultsFive studies were included in the final analysis. Meta-analysis demonstrates...
Lactose intolerance is not infrequent among people of Asian descent, and soy milk is a preferred substitute to dairy in many Asian countries. . A 32-year-old woman with morbid obesity (initial body mass index: 47.9 kg/m2) and past history of lactose intolerance presented to our Emergency Department with intractable belching and vomiting after consuming 300 mL of concentrated soy milk. She had just underwent an uneventful laparoscopic Roux-en-Y gastric bypass (antegastric, antecolic gastrojejunostomy), and was discharged two days prior to re-admission with a two day hospital stay after initial surgery.
ConclusionObesity is closely associated with primary infertility and PCOD. Menstrual abnormalities associated with PCOD significantly improve after bariatric surgery with significant improvement in fertility along with maternal outcomes.
Younger patients and those who lose more weight in the first year after Roux-en-Y gastric bypass (RYGB) have a better chance of achieving lasting type 2 diabetes mellitus (T2D) remission, new research shows.Reuters Health Information
AbstractAimPublished reports showed conflicting results regarding the sustained alterations in leptin, chemerin, and ghrelin concenratios after metabolic surgery. Therefore, we performed the present work to contrast the alterations in leptin, chemerin, and ghrelin levels one year after Roux-en-Y gastric bypass (RYGB) versus laparoscopic sleeve gastrectomy (LSG).MethodsThe present research is a prospective, comparative one that followed 100 cases for whom RYGB or LSG was done. We assessed the serum values of adiposity-associated mediators, including adipokcytokines (leptin and active chemerin) and gastrointestinal hormones ...
CONCLUSION: Improved hepatic glucose metabolism and lower plasma kisspeptin in T2D after RYGB may link improved hepatic function with enhanced insulin responsiveness after surgery. PMID: 31709832 [PubMed - as supplied by publisher]